Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Dry powder formulation comprising a phosphodiesterase inhibitor

Dry powder formulation comprising a phosphodiesterase inhibitor

US Patent 9132121 · Granted Sep 15, 2015

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Process for preparing a dry powder formulation comprising an anticholinergic, a 2023
Process for preparing a dry powder formulation comprising an anticholinergic, a 2021
Dry powder formulation comprising a corticosteroid and a beta-adrenergic for adm2021
Process for preparing a dry powder formulation comprising an anticholinergic, a 2020
Process for preparing a dry powder formulation comprising an anticholinergic, a 2020
Carrier particles for dry powder formulations for inhalation2020
Carrier particles for dry powder formulations for inhalation2020
Process for preparing a dry powder formulation comprising an anticholinergic, a 2019
Process for preparing a dry powder formulation comprising an anticholinergic, a 2018
Dry powder formulation comprising a corticosteroid and a beta-adrenergic for adm2018
Dry powder formulation comprising an anticholinergic, a corticosteroid and a bet2017
Process for preparing carrier particles for dry powders for inhalation2016